Pharmaceutical products for the treatment of genetic connective tissue disorders; selective adrenoreceptor modulators for pharmaceutical purposes, namely, pharmaceutical preparations for the treatment of disorders of collagen production

Selective adrenoreceptor modulators for pharmaceutical purposes, namely, pharmaceutical preparations for the treatment of disorders of collagen production

Pharmaceutical products for the treatment of genetic connective tissue disorders